Anti-Cancer Drugs Journal Issues Research Articles in October 2022 Edition
September 26, 2022
September 26, 2022
LONDON, England, Sept. 26 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its October 2022 edition:
Original Studies:
* Novel natural inhibitors targeting KRAS G12C by computational study
* . . .
Original Studies:
* Novel natural inhibitors targeting KRAS G12C by computational study
* . . .